Mark Identification
GENEVIEVE PROTOCOL
Serial Number
77389950
Filing Date
Feb 6, 2008
Registration Date
Jul 28, 2009
Trademark by
Active Trademark
Classification Information
Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination
Medical, Beauty & Agricultural